We at CYTO365 developes the RondelO turnvalve which is the first of its kind to add. Physical barrier towards drug mixing so that drugs are given correctly one at a time with flushing fluid in between during the administration phase. EIC Accelerator backed since 2022 and we are currently on the market with RondelO iV-set (CE) and components.
Objectives
Topics
Investment
CYTO365 looking for 2MEUR to co-invest with EIC Fund
CYTO365 an early revenue scale up - with proven traction of 22 customers, RondelO solves the problem of drug mixing within infusion therapy.